Experienced in Sjogren Syndrome

Dr. Jamal A. Mikdashi

Rheumatology
University Of Maryland Physicians PA
22 S Green St, 
Baltimore, MD 
Accepting New Patients
Offers Telehealth
Experienced in Sjogren Syndrome
University Of Maryland Physicians PA
22 S Green St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jamal Mikdashi is a Rheumatologist in Baltimore, Maryland. Dr. Mikdashi is rated as an Experienced provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Sarcoidosis, Systemic Lupus Erythematosus (SLE), Neurosarcoidosis, and Cutaneous Lupus Erythematosus (CLE). Dr. Mikdashi is currently accepting new patients.

His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Sjogren Syndrome.

Specialties
Rheumatology
Licenses
Internal Medicine in MD
Hospital Affiliations
University Of Maryland Medical Center
University Of MD Medical Center Midtown Campus
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Options
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 23 Less Insurance Carriers -

Locations

UNIVERSITY OF MARYLAND PHYSICIANS PA
22 S Green St, Baltimore, MD 21201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

22 Total Publications

Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial.
Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial.
Journal: Seminars in arthritis and rheumatism
Published: July 02, 2025
Similar Doctors
Elite in Sjogren Syndrome
Dr. Alan N. Baer
Rheumatology
Elite in Sjogren Syndrome
Dr. Alan N. Baer
Rheumatology

Johns Hopkins University

5601 Lloch Raven Blvd, 
Baltimore, MD 
 (5.3 miles away)
443-444-4714
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alan Baer is a Rheumatologist in Baltimore, Maryland. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is currently accepting new patients.

Elite in Sjogren Syndrome
Dr. Thomas Grader-Beck
Rheumatology
Elite in Sjogren Syndrome
Dr. Thomas Grader-Beck
Rheumatology

Johns Hopkins University

4940 Eastern Ave, 
Baltimore, MD 
 (4.2 miles away)
410-550-0100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Grader-Beck is a Rheumatologist in Baltimore, Maryland. Dr. Grader-Beck is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis. Dr. Grader-Beck is currently accepting new patients.

Elite in Sjogren Syndrome
Dr. Gabor G. Illei
Rheumatology
Elite in Sjogren Syndrome
Dr. Gabor G. Illei
Rheumatology
10 Center Dr Rm 1n110, 
Bethesda, MD 
 (33.2 miles away)
301-496-4072
Languages Spoken:
English

Gabor Illei is a Rheumatologist in Bethesda, Maryland. Dr. Illei is rated as a Distinguished provider by MediFind in the treatment of Sjogren Syndrome. His top areas of expertise are Sjogren Syndrome, Systemic Lupus Erythematosus (SLE), Lupus Nephritis, and Cutaneous Lupus Erythematosus (CLE).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mikdashi's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile